Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. - Wikidata - wikimedia - TriplyDB

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

http://www.wikidata.org/entity/Q34333921

about

Endothelin-1 and its role in the pathogenesis of infectious diseases The pathobiology of vascular dementia Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial.Influence of Circulating Endothelin-1 and Asymmetric Dimethylarginine on Whole Brain Circulation Time in Multiple Sclerosis.Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculation Interleukin-1 and acute brain injury.Cerebral circulation time is prolonged and not correlated with EDSS in multiple sclerosis patients: a study using digital subtracted angiography.Systemic inflammation impairs tissue reperfusion through endothelin-dependent mechanisms in cerebral ischemia.Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.Flavonol-rich dark cocoa significantly decreases plasma endothelin-1 and improves cognition in urban children.Vascular hypoperfusion in acute optic neuritis is a potentially new neurovascular model for demyelinating diseases.Hemodynamic evidence linking cognitive deficits in clinically isolated syndrome to regional brain inflammation.What Have We Learned from Perfusion MRI in Multiple Sclerosis?Brain perfusion by arterial spin labeling MRI in multiple sclerosis.Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation.Cerebral Blood Flow Changes in Multiple Sclerosis and Neuromyelitis Optica and Their Correlations With Clinical Disability.Impaired Cerebral Perfusion in Multiple Sclerosis: Relevance of Endothelial Factors.

P2860

Q26830339-A0FA3E20-5512-4229-B6DF-29D0073B68A2 Q27006033-B3AAE7ED-4800-450C-9263-BEB04D6E7832 Q27027921-BA797016-3976-4CE8-A09B-BD2292E43C21 Q33716611-650BDA69-21E7-41EF-90E3-265970C466A0 Q33773354-97423425-EBE9-4C68-97F1-DBA3A30896EA Q34957350-7405EECB-740C-4DE8-A5F2-051690C61B1A Q35056860-F31CBDC3-DEA4-4F99-8D6D-0B94C5BF3B92 Q35101746-A6308E38-C6E9-4363-8543-9C6A3F58B541 Q35187936-4A58B2CC-08F8-4A24-BF54-20B795DBC36A Q36127630-A45B2DA7-BE1C-4C1B-8720-3128173FDA08 Q37597918-BA611639-65B7-482C-A1F7-06794E2AC85B Q38879090-EDD4E231-4B96-4F65-97DB-D85EE60B3C1F Q40133787-93E0CB46-23AA-4A3E-8549-AAE1F574FD0C Q41677192-0E13E25D-6451-4069-AE65-45A62BA3A797 Q43837534-DFB638F7-32CD-46E9-A715-D8260C70355A Q47883049-031111DE-ABDA-453D-A18C-7F1A3243AB7B Q48157809-C8E9E34B-7EA0-4C0F-B71F-61705048E75D Q52565806-9F47648E-0A64-4C5D-82A3-96951ED76847 Q54935884-E3A6121B-EE59-4104-9C88-C68F813C0D24 Q54940444-EAC730B9-702D-4A82-B77B-8F95D9CB3BFB

P2860

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

http://www.wikidata.org/entity/Q34333921

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

@ast

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

@en

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

@nl

type

label

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

@ast

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

@en

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

@nl

prefLabel

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

@ast

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

@en

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

@nl

P1433

Q34333921-29FAE25C-037E-4C4F-BDD3-14D6A2AC6DE6

P1476

Q34333921-3F07301C-A8F4-4EC9-B927-85651BD36569

P2093

Q34333921-05BD1599-0643-4EC7-B6EE-5FBCFCB65B81

Q34333921-0AECF36C-7D83-4EC7-A615-C48D0190450A

Q34333921-1F7221EC-E0F1-464B-BCD3-6C3212B76A90

Q34333921-6BCFE921-899A-464F-8A5C-F7AB21913578

Q34333921-83917F30-F4F7-444E-AF6C-103CB5A52B8C

Q34333921-83E06166-3EA1-409E-A099-F2A4626826BA

Q34333921-99B29178-781E-41EA-B91C-0182BBAC622D

Q34333921-C74CDC19-CBF9-4520-BD44-85935130EEFA

P2860

Q34333921-015F30CD-E375-4559-94E6-53BC9DBD0D54

Q34333921-0583F3DA-1D5A-475F-A589-17DFA9BFE691

Q34333921-0FCD51C0-B01B-4E38-A2C9-577247ADEB73

Q34333921-2CDCF812-4BDD-4FE3-80A3-B86B225DC2C4

Q34333921-3547772D-91BB-4C42-A03C-E9466269E835

Q34333921-3D1EC4A0-6A18-464D-BF37-F81374127D35

Q34333921-4E2A5E4C-1E13-4A9F-A9D8-B6804E51492A

Q34333921-5197078F-2E35-4C07-91AC-3D0DCB243855

Q34333921-56F327C1-DB4E-4B0D-8DF2-22943D7AE912

Q34333921-5FD8F390-DC8D-4C59-8AC3-8CE62E5A6187

P304

Q34333921-B2291BED-E5CC-43B4-9460-53584BA51C3E

P31

Q34333921-BA5A32F8-695E-4714-B66A-B9A563310B76

P356

Q34333921-09BBDC7E-E598-476A-91C4-BF27A891FCC8

P407

Q34333921-3943CEFC-32DE-417F-A8B6-02F071832BCE

P433

Q34333921-AB52ABBB-3F66-4EFB-84C0-D03D8BFFF6DE

P478

Q34333921-DC639710-D800-4F03-B5C6-70932C47BB8A

P577

Q34333921-1F4390BA-EB83-482A-B897-46393B1B6CAC

P698

Q34333921-630A5D75-7938-449F-87E9-0BC391DB7A85

P921

Q34333921-5355AF96-B153-46DA-AD28-FBE94C8EF46A

P932

Q34333921-89E63096-4D7D-48DE-A307-9D2A9DE1809A

P356

PNAS.1222560110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

@en

P2093

Anne-Marie Vanbinst

http://www.w3.org/2001/XMLSchema#string

Christian Verborgh

http://www.w3.org/2001/XMLSchema#string

Jacques De Keyser

http://www.w3.org/2001/XMLSchema#string

Johan Demey

http://www.w3.org/2001/XMLSchema#string

Melissa Cambron

http://www.w3.org/2001/XMLSchema#string

Miguel D'haeseleer

http://www.w3.org/2001/XMLSchema#string

Roel Beelen

http://www.w3.org/2001/XMLSchema#string

Yves Fierens

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Increased endothelin-1 plasma levels in patients with multiple sclerosis

Multiple sclerosis

Cognitive impairment in multiple sclerosis

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

Pulsed star labeling of arterial regions (PULSAR): a robust regional perfusion technique for high field imaging.

Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat.

Inflammation and white matter damage in vascular cognitive impairment.

Vascular aspects of multiple sclerosis.

P304

5654-5658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1222560110

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23509249

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3619305

http://www.w3.org/2001/XMLSchema#string